We targeted inflammatory S100A proteins and their regulation by inflammatory cytokines mediated by JAK2-STAT, PI3K-AKT, and NF-κB signaling pathways in patients with CLL. The gene discussed is AKT1; the disease is B-cell chronic lymphocytic leukemia.